Glaxosmithkline Pharmaceuticals Ltd. (GLAXO): Glaxosmithkline Pharmaceuticals Share Price hits fresh 52-week high

Published: 27 August 2026 at 10:19 AM IST

GLAXO Share Price is in focus after Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) moved to Rs 3,050 on 27 August 2026, up Rs 22.50 or 0.74% from the previous close of Rs 3,027.50. The stock also touched a fresh 52-week high of Rs 3,067.65 during the session, while market capitalisation stood at Rs 50,483.85 crore. The verified data confirms a new yearly high, but it does not establish a company-specific catalyst for the move.

For readers tracking GLAXO Share Price Today, the session opened at Rs 3,027.50, matched the day’s low of Rs 3,018.70 and reached the high of Rs 3,067.65 before settling at Rs 3,050. That places the stock very close to its fresh 52-week peak. In Univest coverage terms, this is the kind of event that typically draws searches for GLAXO Stock News, GLAXO Share Price News and GLAXO News Today, especially when a stock reaches a fresh yearly high without a disclosed trigger.

On the numbers supplied, the event is relevant because it combines a fresh 52-week high with a large market capitalisation, elevated valuation metrics and strong profitability ratios. Univest is tracking the event as a factual price update rather than as a directional call. The key items to watch next are whether the price continues to hold near the recent high and how the valuation compares with the healthcare and pharmaceuticals peer set.

GLAXO Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 3,050
Previous Close	Rs 3,027.5
Today's Move	+Rs 22.5 (+0.74%)
Open	Rs 3,027.5
High	Rs 3,067.65
Low	Rs 3,018.7
Turnover	Rs 0.47 crore
Market Capitalisation	Rs 50,483.85 crore

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) traded at Rs 3,050 versus the previous close of Rs 3,027.5, a rise of 0.74%. The stock opened at Rs 3,027.5, reached a high of Rs 3,067.65 and touched a low of Rs 3,018.7.

GLAXO Share Price Today shows a narrow intraday range around the upper end of the session. The stock opened at Rs 3,027.50, traded between Rs 3,018.70 and Rs 3,067.65, and closed at Rs 3,050. Compared with the previous close of Rs 3,027.50, the gain was Rs 22.50, or 0.74%. The fresh 52-week high of Rs 3,067.65 is only slightly above the closing price, which means the market has already marked a new yearly high and then eased modestly from the day’s top.

Turnover for the session was Rs 0.47 crore. That is a factual traded-value measure for the day and can be read alongside the price move, not as a conclusion about participation or sentiment. For GLAXO Share Price, the important point is that the stock set a new one-year high and stayed near that level through the close. In share-market language, that is exactly why GLAXO Stock News is being searched today: the price event is clear, and the market data are fresh.

From a daily price perspective, the move was positive, measured and tightly contained. There is no need to stretch the data beyond what it shows. The stock finished above its prior close and at a level that confirms a fresh 52-week high. For Univest readers following GLAXO Share Price Live and GLAXO Share Price Update, the session was notable because the day’s top and the 52-week high were the same at Rs 3,067.65.

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 50,483.85 crore
P/E Ratio	48.02x
P/B Ratio	20.35x
ROE	48.76%
ROCE	66.79%
EPS	Rs 63.05
Book Value Per Share	Rs 148.77
Dividend Yield	1.88%

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) fundamental metrics show P/E 48.02x, P/B 20.35x, ROE 48.76%, ROCE 66.79%. These figures provide context only and are not a buy or sell signal.

Glaxosmithkline Pharmaceuticals Ltd. has a market capitalisation of Rs 50483.85 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 48.02x, P/B at 20.35x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 48.76% and ROCE of 66.79%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 63.05, book value per share of Rs 148.77, dividend yield of 1.88%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 30.54x, median ROE of 11.83%, median ROCE of 13.75%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	48.02x
Benchmark Median P/E	30.54x
Benchmark Average P/E	47.16x
Benchmark P/E Range	3.19x to 671.51x
Company P/B Ratio	20.35x
Benchmark Median P/B	2.76x
Company ROE	48.76%
Benchmark Median ROE	11.83%
Company ROCE	66.79%
Benchmark Median ROCE	13.75%
Company Market Capitalisation	Rs 50,483.85 crore
Benchmark Median Market Cap	Rs 623.8 crore

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a P/E ratio of 48.02x, which is above the benchmark median of 30.54x, a difference of +57.24%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a ROE of 48.76%, which is above the benchmark median of 11.83%, a difference of +312.17%. Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a ROCE of 66.79%, which is above the benchmark median of 13.75%, a difference of +385.75%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Anthem Biosciences Ltd.	ANTHEM	49,292.57	90.34	16.63	21.98	29.62
Ipca Laboratories Ltd.	IPCALAB	48,969.99	37.81	5.84	15.88	19.41
Gland Pharma Ltd.	GLAND	46,538.74	42.46	4.51	10.56	14.96
Abbott India Ltd.	ABBOTINDIA	56,173.06	34.88	10.88	34.67	46.72
Ajanta Pharma Ltd.	AJANTPHARM	44,449.8	39.03	9.12	25.42	32.67

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a P/E ratio of 48.02x compared with the displayed peer median of 39.03x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 48.76% compares with a peer median of 21.98% across the companies shown in the table. ROCE stood at 66.79% versus the displayed peer median of 29.62%, providing a capital-efficiency comparison. Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a market capitalisation of Rs 50,483.85 crore. Among the 5 peers shown, 1 has a larger market capitalisation.

Why Investors Are Watching GLAXO

• GLAXO Share Price closed at Rs 3,050 after touching a fresh 52-week high of Rs 3,067.65.
• The day’s move was Rs 22.50, or 0.74%, versus the previous close of Rs 3,027.50.
• Market capitalisation stood at Rs 50,483.85 crore in the latest snapshot.
• P/E was 48.02, P/B was 20.35, ROE was 48.76 and ROCE was 66.79.
• Within the supplied peer set, GLAXO’s ROE and ROCE were above the listed comparables.

About Glaxosmithkline Pharmaceuticals

Glaxosmithkline Pharmaceuticals Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied company profile confirms the listing identity used for GLAXO Share Price coverage on Univest. This article uses only the verified market and financial fields provided in the data feed, with the company’s classification and key ratios forming the core of the analysis.

For readers following GLAXO Company News, the main factual reference points are the current share price, the fresh 52-week high, market capitalisation, EPS, book value and return ratios. Those elements are enough to place GLAXO Share Price within the broader pharmaceutical context without adding unsupported business detail.

Track GLAXO Share Price on Univest

Use Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Track GLAXO Share Price on Univest for live price updates, 52-week levels, valuation ratios, shareholding pattern, sector context and market insights. Univest also helps readers revisit GLAXO Share Price Today, GLAXO Stock News and GLAXO Share Price Update in one place as new market data arrive.

For users comparing GLAXO Share News with other healthcare names, Univest brings together the same factual fields used in this article so that the stock can be followed alongside peer comparison and company fundamentals.

In conclusion, GLAXO Share Price has reached a fresh 52-week high, and the current data show a strong profitability profile alongside a relatively rich valuation. Univest will continue to track GLAXO Stock News, GLAXO Share Price Today and the next price update as the market forms a new reference point around Rs 3,067.65.

Frequently Asked Questions

What is the current GLAXO Share Price?

Ans. GLAXO Share Price is Rs 3,050. The stock closed Rs 22.50, or 0.74%, above the previous close of Rs 3,027.50 after touching a fresh 52-week high of Rs 3,067.65 in the session.

Did GLAXO hit a fresh 52-week high today?

Ans. Yes. GLAXO touched Rs 3,067.65, which is the fresh 52-week high in the supplied data. The closing price was slightly lower at Rs 3,050, but the yearly high was set during the day.

What does GLAXO Share Price Today show?

Ans. GLAXO Share Price Today shows a small gain from the previous close, a new yearly high and a close near the day’s top. The session opened at Rs 3,027.50 and traded within a narrow range.

How is GLAXO valued on the supplied numbers?

Ans. GLAXO has a P/E of 48.02 and a P/B of 20.35. Both are above the industry medians in the supplied benchmark set, while ROE and ROCE are also well above the same comparison group.

What do GLAXO EPS and book value mean?

Ans. GLAXO EPS is Rs 63.05 and book value per share is Rs 148.77. EPS shows earnings attributable to each share, while book value reflects accounting net worth per share at the latest reported point.

How does GLAXO compare with pharmaceutical peers?

Ans. In the supplied peer list, GLAXO’s ROE of 48.76 and ROCE of 66.79 are above the listed comparables. Its market capitalisation is also larger than several peers in the comparison set.

Where can I track GLAXO Share Price on Univest?

Ans. Univest tracks GLAXO Share Price with live updates, 52-week levels, valuation ratios, shareholding pattern and sector context. Readers can use the platform to revisit the same verified market data as new snapshots appear.